Compass Pathways' latest update reveals extended trial timelines, staff cuts, and financial concerns, raising questions about ...
Bright Minds Biosciences' BMB-101 shows promise in treating drug-resistant epilepsy. Read why DRUG stock is a strong ...
MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 ...
A Phase 3 clinical trial investigating Elevidys (delandistrogene moxeparvovec), a gene therapy for Duchenne muscular ...
Athira Pharma (ATHA) announced that results from the Phase 2/3 LIFT-AD clinical trial of fosgonimeton to treat Alzheimer’s disease will ...
MyChesCo on MSN14d
Marinus Pharmaceuticals Unveils Promising Phase 3 Trial Results for IV Ganaxolone in Treating Refractory Status EpilepticusRADNOR, PA — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) showcased new findings from its pivotal Phase 3 RAISE trial at the ...
Bagsværd, Denmark Tuesday, November 5, 2024, 10:00 Hrs [IST] ...
With a positive readout for metabolic dysfunction-associated steatohepatitis (MASH) now in the bag, Novo Nordisk is gearing ...
News Medical on MSN9d
Phase 3 trial assesses clazakizumab in kidney transplant recipients with caAMRChronic active antibody-mediated rejection (caAMR) is a common cause of allograft loss after transplantation, with no approved therapies. Clazakizumab, a monoclonal antibody that targets the ...
Three phase 3 trials of combinations including datopotamab deruxtecan for the treatment of non–small cell lung cancer are beginning.
"We are happy to have completed enrollment for our Phase 2a RIVER trial for the treatment of RCC," said Jennifer Good, President and CEO of Trevi Therapeutics. "RCC impacts approximately 2-3 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback